posted on 2024-10-25, 12:19authored byTobias KammannTobias Kammann, Curtis CaiCurtis Cai, Takuya SekineTakuya Sekine, Elli Mouchtaridi, Caroline Boulouis, Vera Nilsén, Olga Rivera Ballesteros, Thomas R Müller, Yu Gao, Elisa JM Raineri, Akhirunnesa Mily, Sarah Adamo, Christian Constantz, Julia Niessl, Whitney Weigel, Efthymia Kokkinou, Christopher Stamper, Anne Marchalot, John Bassett, Sabrina Ferreira, Inga Rødahl, Nicole Wild, Demi Brownlie, Christopher TibbittChristopher Tibbitt, Jeffrey YW Mak, David P Fairlie, Edwin Leeansyah, Jakob Michaelsson, Nicole Marquardt, Jenny Mjösberg, Carl JornsCarl Jorns, Marcus Buggert, Johan SandbergJohan Sandberg
Mucosal-associated invariant T (MAIT) cells are unconventional T cells that recognize microbial riboflavin pathway metabolites presented by evolutionarily conserved MR1 molecules. We explored the human MAIT cell compartment across organ donor-matched blood, barrier, and lymphoid tissues. MAIT cell population size was donor dependent with distinct tissue compartmentalization patterns and adaptations: Intestinal CD103+ resident MAIT cells presented an immunoregulatory CD39highCD27low profile, whereas MAIT cells expressing NCAM1/CD56 dominated in the liver and exhibited enhanced effector capacity with elevated response magnitude and polyfunctionality. Both intestinal CD39high and hepatic CD56+ adaptations accumulated with donor age. CD56+ MAIT cells displayed limited T cell receptor-repertoire breadth, elevated MR1 binding, and a transcriptional profile skewed toward innate activation pathways. Furthermore, CD56 was dynamically up-regulated to a persistent steady-state equilibrium after exposure to antigen or IL-7. In summary, we demonstrate functional heterogeneity and tissue site adaptation in resident MAIT cells across human barrier tissues with distinct regulatory and effector signatures.
Funding
Mapping of viral reservoirs and effective immune responses to HIV in tissues : Swedish Research Council | 2021-01141_VR
Understanding and preventing NK cell-mediated lung tissue-damage upon severe respiratory viral infections : Swedish Research Council | 2021-01039_VR
Identifying and harnessing NK cell subsets in the human lung for treatment of lung cancer. : Swedish Research Council | 2021-03069_VR
Covid-19 vaccination in immunocompromised individuals: An interdisciplinary framework to gain clinical and mechanistic insight into durable immunity to SARS-CoV-2 infection : Swedish Research Council | 2021-04779_VR
Interdisciplinary framework on the role of adaptive cellular immunity in SARS-CoV-2 protection : Swedish Research Council | 2020-06121_VR
Defining heterogeneity and viral control mechanisms of lymphoid resident memory T cells in health and HIV disease : Swedish Research Council | 2018-02330_VR
Impact of location and genetics on human virus-specific CD8+ T cell differentiation and function : Swedish Research Council | 2022-01313_VR